论文部分内容阅读
目的比较舒芬太尼与曲马多对小儿腹腔镜手术围术期恢复质量的影响。方法 90例小儿腹腔镜全麻患儿随机分成3组,各30例,即对照组(A组)、舒芬太尼组(B组)和曲马多组(C组)。所有患者均给予配伍相同的诱导用药和维持用药。术毕记录呼吸恢复、呼之睁眼、意识及定向力恢复、拔管和离开手术室的时间及拔管时呛咳及躁动的发生率;记录拔管即刻、离开手术室和术后1 h的意识状态OAAS评分。结果 B组、C组的呼吸恢复、呼之睁眼、意识恢复、定向力恢复和离开手术室的时间明显延长于A组,差异均有统计学意义(P<0.05),B组、C组上述参数组间比较均无显著性差异(P>0.05);3组拔管时间差异无统计学意义(P>0.05);B组和C组拔管后呛咳、躁动发生率较A组显著降低;B组、C组拔管即刻和离开手术室时术后OAAS评分明显高于A组差异均有统计学意义(P<0.05);拔管后1 h3组术后OAAS评分差异无统计学意义(P>0.05)。结论舒芬太尼与曲马多都能减轻小儿腹腔镜手术围术期机体的应激反应,提高恢复质量,舒芬太尼并发症更少、效果更优。
Objective To compare the effects of sufentanil and tramadol on the perioperative recovery of pediatric laparoscopic surgery. Methods Ninety children with pediatric laparoscopic general anesthesia were randomly divided into three groups (n = 30 each): control group (group A), sufentanil group (group B) and tramadol group (group C). All patients were given compatibility with the same induction medication and maintenance medication. Recorded respiratory recovery surgery, call the eyes open, awareness and orientation recovery, extubation and leave the operating room time and extubation cough and agitation rate; record extubation immediately after leaving the operating room and 1 h The state of consciousness OAAS score. Results In group B and group C, the time of breathing recovery, eye opening, consciousness recovery, directionality recovery and leaving the operating room were significantly prolonged in group A, with significant difference (P <0.05). Group B and group C There was no significant difference between the above parameters (P> 0.05); there was no significant difference in extubation time among the three groups (P> 0.05); the incidences of cough and agitation after extubation in group B and C were significantly higher than those in group A (P <0.05). There was no significant difference in postoperative OAAS score between group B and group C after extubation immediately after leaving the operating room Significance (P> 0.05). Conclusion Both sufentanil and tramadol alleviate the perioperative stress response in pediatric laparoscopic surgery and improve the quality of recovery with fewer sufentanil complications and better efficacy.